Board of Directors of the Fredun Pharmaceuticals Limited at its meeting held on May 16, 2022 approved the Recommended Final Dividend at 7% per Equity Share having face value of INR 10/- each for the Financial Year 2021-22; subject to the approval of the shareholders at the upcoming 35th Annual General Meeting of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
880.4 INR | 0.00% | +3.08% | +1.35% |
May. 10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
May. 08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
+1.35% | 49.67M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.77% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year 2021-22